Substitution infusion fluid and citrate anticoagulation

An aqueous substitution infusion fluid for pure hemofiltration of blood using citrate as anticoagulant comprising about 100 mmol/L of sodium ions, about 2.1 mmol/L of calcium ions, about 2.2 mmol/L of potassium ions, about 0.6 mmol/L of phosphate ions, about 0.8 mmol/L of magnesium ions, about 7.0 mmol/L of glucose, less than 3.1 mmol/L of acetate ions, and chloride ions to keep electrochemical balance.

An aqueous substitution infusion fluid for pure hemofiltration of blood using citrate as anticoagulant comprising about 107 mmol/L of sodium ions, about 2.3 mmol/L of calcium ions, about 2.5 mol/L of potassium ions, about 0.8 mmol/L of phosphate ions, about 0.9 mmol/L of magnesium ions, about 6.4 mmol/L of glucose, less than 5.5 mmol/L of acetic acid, and chloride ions to keep electrochemical balance.

An aqueous substitution infusion fluid for pure hemofiltration of blood using citrate as anticoagulant comprising about 118 mmol/L of sodium ions, about 2.3 mmol/L of calcium ions, about 2.6 mmol/L of potassium ions, about 0.8 mmol/L of phosphate ions, about 0.9 mmol/L of magnesium ions, about 6.5 mmol/L of glucose, less than 5.5 mmol/L of acetic acid, and chloride ions to keep electrochemical balance.

A citrate anticoagulation solution for anticoagulation of circulating blood during pure hemofiltration, comprising between 19 and 135 mmol/L of citric acid and between 106 and 290 mmol/L of trisodium citrate.

A citrate anticoagulation solution for anticoagulation during pure hemofiltration of blood being an aqueous solution comprising about 38 mmol/L of citric acid and about 212 mmol/L of trisodium citrate.